Asset Dedication LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

Asset Dedication LLC’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50	Closed	-$1.32K	–	1244
2026 Q1	$1.32K	Hold	50	–	–	﹤0.01%	1000
2025 Q4	$1.45K	Hold	50	–	–	﹤0.01%	1025
2025 Q3	$1.39K	Hold	50	–	–	﹤0.01%	1047
2025 Q2	$1.22K	Hold	50	–	–	﹤0.01%	1072
2025 Q1	$1.04K	Hold	50	–	–	﹤0.01%	1018
2024 Q4	$1.18K	Hold	50	–	–	﹤0.01%	1008
2024 Q3	$1.28K	Sell	50 -124	-71%	-$3.16K	﹤0.01%	1044
2024 Q2	$4.09K	Hold	174	–	–	﹤0.01%	962
2024 Q1	$5K	Hold	174	–	–	﹤0.01%	771
2023 Q4	$6K	Hold	174	–	–	﹤0.01%	749
2023 Q3	$4K	Hold	174	–	–	﹤0.01%	806
2023 Q2	$6K	Hold	174	–	–	﹤0.01%	729
2023 Q1	$6K	Hold	174	–	–	﹤0.01%	711
2022 Q4	$5K	Hold	174	–	–	﹤0.01%	741
2022 Q3	$6K	Hold	174	–	–	﹤0.01%	683
2022 Q2	$6K	Hold	174	–	–	﹤0.01%	376
2022 Q1	$8K	Hold	174	–	–	﹤0.01%	677
2021 Q4	$11K	Sell	174 -350	-67%	-$24.2K	﹤0.01%	629
2021 Q3	$38K	Buy	524 +179	+52%	+$15K	0.01%	461
2021 Q2	$31K	Buy	345 +50	+17%	+$4.25K	﹤0.01%	468
2021 Q1	$26K	Buy	295 +245	+490%	+$24.3K	0.01%	403
2020 Q4	$5K	Buy	+50	New	+$3.98K	﹤0.01%	624

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Asset Dedication LLC's ARKG Position: Q2 2026 in Review

Asset Dedication LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 50 shares — an estimated $1.32K sold.

Asset Dedication LLC first reported a position in ARKG in Q4 2020 and held it in 22 quarters. The position peaked at $38K in Q3 2021. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Asset Dedication LLC reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
Asset Dedication LLC sold 50 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.32K.
Asset Dedication LLC first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 22 quarters.
Asset Dedication LLC's ARK Genomic Revolution ETF position peaked at $38K in Q3 2021.
274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.